Emperor - Reduced Trial

EMPEROR - REDUCED TRIAL

Conarec Oficial

EMPEROR Reduced trial results - Milton Packer, MD

EMPEROR-Reduced: Empagliflozin benefits in HF patients irrespective of diabetes | Milton Packer

Medicine Matters diabetes

EASD2021 EMPEROR-Reduced Trial what doesit meaning for the future?

European Association for the Study of Diabetes

Dr John McMurray Compares EMPEROR-Reduced Findings with DAPA-HF

ESC TV at ESC Congress 2020 - EMPEROR-Reduced (Investigator)

European Society of Cardiology

EMPEROR-Reduced: Time for a change in the HF guidelines? | Miles Fisher

Medicine Matters diabetes

Dr Milton Packer Discusses the Combined Impact of EMPEROR-Reduced, DAPA-HF

Dr Vinod Mittal - Landmark Trials in Heart Failure: DAPA-HF & EMPEROR-Reduced

ESC 2020 Discussion: The EMPEROR-Reduced Study — Dr Milton Packer & Dr Harriette Van Spall

Radcliffe Cardiology

EMPEROR Preserved | EMPEROR Pooled Trial Results

SGLT2 Inhibitors and Heart Failure

Harvard Medical School Continuing Education

Darrel Francis Interview with Milton Packer:the EMPEROR-Reduced Trial,the Patients and the Endpoints

CVCT Cardiobrief

COVID 19 "REINFECTION" AND THE "EMPEROR REDUCED" TRIAL

Dr. Deepak Natarajan

EMPEROR REDUCED TRIAL

EMPEROR Preserved: Empagliflozin in heart failure with preserved ejection fraction

Cardiology Update

09 Stefan Anker The EMPEROR study Program in Heart Failure Past, Present and Future

Emirates Cardiac Society

Robert Busch, MD: Reaction to EMPEROR-Reduced Topline Results

Practical Cardiology

EMPULSE: The ‘missing link’ for empagliflozin in heart failure | Adriaan Voors

Medicine Matters diabetes

Ateneo Bibliográfico - Emperor Reduced Trial

Residencia de Cardiología HMC